?Effect of exercise and pomegranate concentrate on metabolic syndrome

The effect of aerobic and resistance exercise with and without pomegranate concentrate on lipid profiles and glycemic Indices in inactive obese women with metabolic syndrome

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20181029041491N1

Enrollment

Registered

2018-11-28

Start date

2018-08-01

Completion date

Unknown

Last updated

2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

metabolic syndrome. Obesity, unspecified

Interventions

Intervention 1: Intervention group: consume a daily amount of pomegranate concentrate (50 g) in two meals of 25 g after lunch and dinner. Intervention 2: Intervention group: combination of aerobic and

No pomegranate concentrate consumption.

Eligibility

Sex/Gender

Female

Age

35 Years to 45 Years

Inclusion criteria

Inclusion criteria: inactive obese women (35-45 age ) with metabolic syndrome 32>BMI>27 no training course for at least 2 months prior to the training no affliction with chronic diseases such as cardiovascular, renal disorders, or thyroid disorders no menopause non-smokers consuming no medications

Exclusion criteria

Exclusion criteria: Unwillingness to continue the study the disease that requires special treatments Severe change in diet

Design outcomes

Primary

Measure	Time frame
Fasting blood sugar. Timepoint: 24 hours prior to the protocol and 48 hours after the last protocol session. Method of measurement: Blood sampling.;Fasting insulin. Timepoint: 24 hours prior to the protocol and 48 hours after the last protocol session. Method of measurement: Blood sampling.;Glycosylated hemoglobin. Timepoint: 24 hours prior to the protocol and 48 hours after the last protocol session. Method of measurement: Blood sampling.;C-peptide. Timepoint: 24 hours prior to the protocol and 48 hours after the last protocol session. Method of measurement: Blood sampling.;Cholesterol. Timepoint: 24 hours prior to the protocol and 48 hours after the last protocol session. Method of measurement: Blood sampling.;TG. Timepoint: 24 hours prior to the protocol and 48 hours after the last protocol session. Method of measurement: Blood sampling.;HDL. Timepoint: 24 hours prior to the protocol and 48 hours after the last protocol session. Method of measurement: Blood sampling.;LDL. Timepoint: 24 hours prior to the protocol and 48 hours after the last protocol session. Method of measurement: Blood sampling.;Insulin Resistance. Timepoint: 24 hours prior to the protocol and 48 hours after the last protocol session. Method of measurement: homeostasis model assessment (HOMA-IR) formula.	—

Measure

Time frame

Fasting blood sugar. Timepoint: 24 hours prior to the protocol and 48 hours after the last protocol session. Method of measurement: Blood sampling.;Fasting insulin. Timepoint: 24 hours prior to the protocol and 48 hours after the last protocol session. Method of measurement: Blood sampling.;Glycosylated hemoglobin. Timepoint: 24 hours prior to the protocol and 48 hours after the last protocol session. Method of measurement: Blood sampling.;C-peptide. Timepoint: 24 hours prior to the protocol and 48 hours after the last protocol session. Method of measurement: Blood sampling.;Cholesterol. Timepoint: 24 hours prior to the protocol and 48 hours after the last protocol session. Method of measurement: Blood sampling.;TG. Timepoint: 24 hours prior to the protocol and 48 hours after the last protocol session. Method of measurement: Blood sampling.;HDL. Timepoint: 24 hours prior to the protocol and 48 hours after the last protocol session. Method of measurement: Blood sampling.;LDL. Timepoint: 24 hours prior to the protocol and 48 hours after the last protocol session. Method of measurement: Blood sampling.;Insulin Resistance. Timepoint: 24 hours prior to the protocol and 48 hours after the last protocol session. Method of measurement: homeostasis model assessment (HOMA-IR) formula.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammadali Sardar

Mashhad University of Medical Sciences

sardarma@mums.ac.ir+98 51 3800 2178

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026